2026 ICD-10-CM Diagnosis Code D86.9Sarcoidosis, unspecified
ICD-10-CM Codes›D50–D89›D80-D89›D86
- Billable — Valid for Submission
- Chronic Condition
D86.9 is a billable ICD-10-CM diagnosis code for sarcoidosis, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 196 through 198. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Immunity disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Dilated cardiomyopathy due to sarcoidosis
- Duodenal ulcer due to sarcoidosis
- Gastric ulcer due to sarcoidosis
- Gingival disease due to sarcoidosis
- Hypercalcemia due to sarcoidosis
- Hypothyroidism due to infiltrative disease
- Hypothyroidism due to sarcoidosis
- Pulmonary hypertension in sarcoidosis
- Pulmonary hypertension in systemic disorder
- Restrictive cardiomyopathy secondary to sarcoidosis
- Sarcoid panuveitis
- Sarcoid uveitis
- Sarcoidosis
- Sarcoidosis-induced erythema nodosum
- Secondary restrictive cardiomyopathy
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Sarcoidosis - D86.9
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Sarcoid
- Boeck's
- Sarcoidosis
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Sarcoidosis
an idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. it usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.Sarcoidosis, Pulmonary
sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. the clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (cecil textbook of medicine, 19th ed, p431)
Patient EducationClinical
Sarcoidosis
Sarcoidosis is a condition in which groups of cells in your immune system form small, red, and swollen (inflamed) lumps. These lumps are called granulomas. They can form in any organ in the body. But they most commonly affect the lungs and lymph nodes in the chest. Over time, sarcoidosis can cause permanent scarring of organs.
The full article covers:
- What is sarcoidosis?
- What causes sarcoidosis?
- Who is more likely to develop sarcoidosis?
- What are the symptoms of sarcoidosis?
- What other problems can sarcoidosis cause?
- How is sarcoidosis diagnosed?
- What are the treatments for sarcoidosis?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D86.9 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D86.9Overview
Is D86.9 (Sarcoidosis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report sarcoidosis, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D86.9 group to?
When sarcoidosis, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 196, 197, 198, with relative weights from 0.7162 to 1.8872 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of D86.9?
Under the General Equivalence Mappings, sarcoidosis, unspecified converts to ICD-9-CM 135 (sarcoidosis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
